People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Pharmaceuticals, Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuvation Bio Inc. | — | Pharmaceuticals | Series D+ | $275.3M | $9.7B | 2019 |
| Astute Medical, Inc. | — | Healthtech | Series C | $167.8M | $1.1B | 2010 |
| Predictive Biosciences, Inc | — | Biotechnology | Series B | $26.8M | $1.0B | 2010 |
Kim Blickenstaff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kim Blickenstaff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| James Blair | 1 | 8 |
| M. James Barrett | 1 | 6 |
| James Barrett | 1 | 6 |
| Claudio Nessi | 1 | 5 |
| David Douglass | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Jay Moorin | 1 | 4 |
| Vikram Lamba | 1 | 4 |
| Kathryn E. Falberg | 1 | 3 |
| Frederick Dotzler | 1 | 3 |
| Michelle Doig | 1 | 3 |
| Peter Klemm | 1 | 3 |
| James Scopa | 1 | 3 |
| Kenneth Buechler | 1 | 3 |
| W. Anthony Vernon | 1 | 2 |
| Ellen E. Sheets | 1 | 2 |
| Robert Bazemore | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.